This Article Full Text Full Text (PDF) All Versions of this Article: 40/11/3638    most recent STROKEAHA.109.559450v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Orken, D. N. Articles by Forta, H. PubMed PubMed Citation Articles by Orken, D. N. Articles by Forta, H. Related Collections Secondary prevention Coumarins Acute Cerebral Infarction Computerized tomography and Magnetic Resonance Imaging Anticoagulants

(Stroke. 2009;40:3638.)
© 2009 American Heart Association, Inc.

Research Letters

Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment

Dilek Necioglu Orken, MD; Gulay Kenangil, MD; Ender Uysal, MD Hulki Forta, MD

From the Departments of Neurology (D.N.O., G.K., H.F.) and Radiology (E.U.), Sisli Etfal Education and Research Hospital, Istanbul, Turkey.

Correspondence to Dilek Necioglu Orken, Emirhan cd. No:41/12 Dikilitas 34349 Istanbul, Turkey. E-mail dilek.necioglu{at}gmail.com

Background and Purpose— Cerebral microbleeds (CMBs) are known to be indicative of bleeding prone microangiopathy. Little is known about its significance in anticoagulated patients. We aimed to determine the frequency of CMBs in ischemic stroke patients on warfarin treatment.

Methods— A total of 141 ischemic stroke patients on warfarin therapy were enrolled in this study. One hundred five patients with similar demographic features who do not use warfarin were chosen as controls. We compared vascular risk factors and radiological findings including CMBs and leukoaraiosis between the groups.

Results— CMBs on gradient-echo MRI (GE-MRI) were found in 31 patients (22%) and 17 controls (16%) and there was not a significant difference between 2 groups (P=0.25). Study patients with CMBs were older than patients without CMBs (P=0.04) and frequency of leukoaraiosis was significantly higher (P=0.008). Mean duration of warfarin treatment was not different between the patients with and without CMBs (P=0.83).

Conclusion— Although patients with CMBs were older and had more leukoaraiosis the impact of warfarin treatment on CMBs is still controversial.

Key Words: cerebral microbleeds • warfarin • ischemic stroke • magnetic resonance imaging